Sona Nanotech Company Description

Sona Nanotech Inc., nanotechnology life sciences company, manufactures and sells gold nanorod products for diagnostic tests.

The company also provides Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in saliva specimens from individuals, who are suspected of COVID-19; Gemini gold nanorods; Omni gold nanorods for medical applications; and contract services.

Its products are used in various applications, including drug delivery, food and beverage testing, environmental testing, cell imaging, cancer treatment, and liposuction therapy, as well as medical and consumer, military, and veterinary diagnostics.

The company is based in Halifax, Canada.

Sona Nanotech Inc.

Country	Canada
Founded	2013
Industry	Diagnostics & Research
Sector	Healthcare
Employees	10
CEO	David Regan

Contact Details

Address: Purdy’s Wharf Tower II Halifax, NS NS Canada
Phone	902-442-0653

Stock Details

Ticker Symbol	SONA
Exchange	Canadian Securities Exchange
Fiscal Year	November - October
Reporting Currency	CAD
ISIN Number	CA83541C1059
SIC Code	1000

Key Executives

Name	Position
David Andrew Regan	Chief Executive Officer
Robert William George Randall CPA	Chief Financial Officer and Corporate Secretary
Dr. Len Pagliaro Ph.D.	CSO and Director
Dr. Carman Giacomantonio M.D., M.Sc.	Chief Medical Officer
Dr. Kulbir Singh Ph.D.	Co-Founder and Head of Research & Development
Dr. Mike McAlduff	Director of Research & Development and Production and Founder
Dr. Gerrard Marangoni	Co-Founder and Member of Scientific Advisory Board
Darren Rowles	Head of Diagnostics